WO2012017128A3 - Composición a base de extracto de romero y vitamina e y sus aplicaciones - Google Patents

Composición a base de extracto de romero y vitamina e y sus aplicaciones Download PDF

Info

Publication number
WO2012017128A3
WO2012017128A3 PCT/ES2011/070586 ES2011070586W WO2012017128A3 WO 2012017128 A3 WO2012017128 A3 WO 2012017128A3 ES 2011070586 W ES2011070586 W ES 2011070586W WO 2012017128 A3 WO2012017128 A3 WO 2012017128A3
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
rosemary extract
composition based
menopause
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ES2011/070586
Other languages
English (en)
French (fr)
Other versions
WO2012017128A1 (es
WO2012017128A2 (es
Inventor
Enrique De Miguel Del Campo
Guillermo Reglero Rada
Carlota Largo Aramburu
Fornari Reale
Mónica RODRÍGUEZ GARCÍA-RISCO
Laura Jaime De Pablo
Susana Santoyo Diez
Francisco Javier SEÑORANS RODRÍGUEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Autonoma de Madrid
Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz
Original Assignee
Universidad Autonoma de Madrid
Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Autonoma de Madrid, Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz filed Critical Universidad Autonoma de Madrid
Publication of WO2012017128A1 publication Critical patent/WO2012017128A1/es
Publication of WO2012017128A2 publication Critical patent/WO2012017128A2/es
Publication of WO2012017128A3 publication Critical patent/WO2012017128A3/es
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La composicióncomprende un extracto de romero y vitamina E, y puede ser utilizada como suplemento nutricional así como en la elaboración de composiciones farmacéuticas para reducir los procesos inflamatorios y la peroxidación lipídica en general, y, en particular los asociados con la menopausia, así como para laprevención y/oeltratamientodelos efectosadversos de las radiaciones ionizantes.
PCT/ES2011/070586 2010-08-05 2011-08-05 Composición a base de extracto de romero y vitamina e y sus aplicaciones Ceased WO2012017128A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201031225A ES2374482B1 (es) 2010-08-05 2010-08-05 Composición para la reducción de síntomas asociados a la menopausia.
ESP201031225 2010-08-05

Publications (3)

Publication Number Publication Date
WO2012017128A1 WO2012017128A1 (es) 2012-02-09
WO2012017128A2 WO2012017128A2 (es) 2012-02-09
WO2012017128A3 true WO2012017128A3 (es) 2012-03-08

Family

ID=45541172

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2011/070586 Ceased WO2012017128A2 (es) 2010-08-05 2011-08-05 Composición a base de extracto de romero y vitamina e y sus aplicaciones

Country Status (2)

Country Link
ES (1) ES2374482B1 (es)
WO (1) WO2012017128A2 (es)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040048919A1 (en) * 2002-07-02 2004-03-11 Dreon Darlene M. Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
US20070141170A1 (en) * 2005-12-20 2007-06-21 Alcon Manufacturing, Ltd. Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
US20070253941A1 (en) * 2006-04-28 2007-11-01 Naidu A Satyanarayan Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
WO2007141764A1 (en) * 2006-06-08 2007-12-13 The Iams Company Use of at least one polyphenol for promoting eye health
EP1902631A2 (fr) * 2006-09-19 2008-03-26 Institut National de Recherche Agronomique Additif antioxydant naturel d'origine végétale destiné à la nutrition animale
WO2009136410A2 (en) * 2008-04-19 2009-11-12 Nisarga Biotech Pvt. Ltd. Herbal composition for reducing add/adhd and method thereof
US20100048512A1 (en) * 2006-12-01 2010-02-25 National Institute Of Radiological Sciences Radiation protection drug containing tocopherol or tocotrienol compound ester derivative as active ingredient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352712B1 (en) * 1999-04-30 2002-03-05 Daniel O. Lukaczer Dietary supplements for treating fatigue-related syndromes
NO20081487L (no) * 2008-03-27 2009-09-28 Smartfish As Helsefremmende drikk
US20100178369A1 (en) * 2009-01-15 2010-07-15 Nicole Lee Arledge Antioxidant-stabilized concentrated fish oil

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040048919A1 (en) * 2002-07-02 2004-03-11 Dreon Darlene M. Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
US20070141170A1 (en) * 2005-12-20 2007-06-21 Alcon Manufacturing, Ltd. Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
US20070253941A1 (en) * 2006-04-28 2007-11-01 Naidu A Satyanarayan Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
WO2007141764A1 (en) * 2006-06-08 2007-12-13 The Iams Company Use of at least one polyphenol for promoting eye health
EP1902631A2 (fr) * 2006-09-19 2008-03-26 Institut National de Recherche Agronomique Additif antioxydant naturel d'origine végétale destiné à la nutrition animale
US20100048512A1 (en) * 2006-12-01 2010-02-25 National Institute Of Radiological Sciences Radiation protection drug containing tocopherol or tocotrienol compound ester derivative as active ingredient
WO2009136410A2 (en) * 2008-04-19 2009-11-12 Nisarga Biotech Pvt. Ltd. Herbal composition for reducing add/adhd and method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PENG, C.-H. ET AL.: "Supercritical fluid extracts of rosemary leaves exhibit potent anti-inflammation and anti-tumor effects.", BIOSCIENCE, BIOTECHNOLOGY AND BIOCHEMISTRY, vol. 71, no. 9, 2007, pages 2223 - 2232 *

Also Published As

Publication number Publication date
ES2374482B1 (es) 2012-12-27
WO2012017128A2 (es) 2012-02-09
ES2374482A1 (es) 2012-02-17

Similar Documents

Publication Publication Date Title
WO2008153945A3 (en) Nutraceutical co-crystal compositions
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
HK1205942A1 (en) Compositions, methods, and kits for regulating energy metabolism
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
WO2016086206A8 (en) Probiotic compositions containing clostridiales for inhibiting inflammation
WO2012074930A3 (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
PH12012501755A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
MX367861B (es) Una composición nutricional para usarse en la preservación del músculo esquelético.
WO2013150386A3 (en) Compositions comprising omega-3 fatty acids and vitamin d for acne vulgaris and/or eczema, and methods and uses thereof
PH12017500641A1 (en) Nutritional compositions comprising an oxidizablecomponent and water-soluble plant extract
HK1212251A1 (en) Topical compositions and methods of use
EP3878445A3 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2011104652A3 (en) Veterinary compositions
GB201316021D0 (en) Vitamin D composition
WO2015067336A3 (en) Conjugated polymers
EP2575842A4 (en) COMPOSITION COMPRISING THE EXTRACT OF PHYSALIS ALKEKENGI VAR. FRANCHETI HORT AS AN ACTIVE INGREDIENT FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES
MX2012007587A (es) Composiciones nutricionales que comprenden hojuelas de frutas que incluyen acido docosahexaenoico.
AU2012345659A8 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2013100718A3 (ko) 라저스트로에미아 오바리폴리아 추출물 또는 이의 분획물을 유효성분으로 포함하는 염증성 질환 또는 천식의 예방 또는 치료용 약학적 조성물
WO2012134172A3 (ko) 오미자 에틸아세테이트 분획물 또는 이로부터 분리한 우웨이지수 ｃ를 유효성분으로 포함하는 비만 예방 또는 치료용 조성물
BR112012029988A2 (pt) composição antioxidante sinérgica
WO2011019867A3 (en) Dietary supplements and methods for treating pain and inflammation
WO2013037985A8 (en) Pharmaceutical combinations including anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
WO2012036414A3 (ko) 발효콩 추출 분획물을 유효 성분으로 포함하는 화장료 조성물

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11814154

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11814154

Country of ref document: EP

Kind code of ref document: A2